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Abstract
Background: Our previous proteomic analysis revealed that mitogen-activated protein kinase activator with WD40
repeats (MAWD) and MAWD-binding protein (MAWBP) were downregulated in gastric cancer (GC) tissues. These
proteins interacted and formed complexes in GC cells. To investigate the role of MAWD and MAWBP in GC
differentiation, we analyzed the relationship between MAWD/MAWBP and clinicopathologic characteristics of GC
tissues and examined the expression of E-cadherin and pepsinogen C (PGC)—used as gastric mucosa differentiation
markers—in MAWD/MAWBP-overexpressing GC cells and xenografts.
Methods: We measured MAWD, MAWBP, transforming growth factor-beta (TGF-beta), E-cadherin, and PGC expression
in 223 GC tissues and matched-adjacent normal tissues using tissue microarray and immunohistochemistry (IHC)
analyses, and correlated these expression levels with clinicopathologic features. MAWD and MAWBP were
overexpressed alone or together in SGC7901 cells and then E-cadherin, N-cadherin, PGC, Snail, and p-Smad2
levels were determined using western blotting, semiquantitative RT-PCR, and immunofluorescence analysis.
Alkaline phosphatase (AKP) activity was measured to investigate the differentiation level of various transfected
cells, and the transfected cells were used in tumorigenicity assays and for IHC analysis of protein expression in
xenografts.
Results: MAWD/MAWBP positive staining was significantly lower in GC tissues than in normal samples (P < 0.001),
and the expression of these proteins was closely correlated with GC differentiation grade. Kaplan–Meier survival
curves indicated that low MAWD and MAWBP expression was associated with poor patient survival (P < 0.05). The
differentiation-related proteins E-cadherin and PGC were expressed in GC tissues at a lower level than in normal
tissues (P < 0.001), but were upregulated in MAWD/MAWBP-overexpressing cells. N-cadherin and Snail expression
was strongr in vector-expressing cells and comparatively weaker in MAWD/MAWBP co-overexpressing cells.
MAWD/MAWBP co-overexpression inhibited Smad2 phosphorylation and nuclear translocation (P < 0.05), and
AKP activity was lowest in MAWD/MAWBP coexpressing cells and highest in vector-expressing cells (P < 0.001).
TGF-beta, E-cadherin, and PGC expression in xenograft tumors derived from MAWD/MAWBP coexpressing cells
was higher than that in control.
Conclusions: MAWD and MAWBP were downregulated and associated with the differentiation grade in GC tissues.
MAWD and MAWBP might induce the expression of differentiation-related proteins by modulating TGF-beta signaling
in GC cells.
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Background
Gastric cancer (GC) is one of the most common malig-
nancies worldwide and ranks second in terms of global
cancer-related mortality [1]. Host genetic factors as well
as bacterial virulence, environmental, and several other
factors have been shown to affect the gastric oncogenic
process, but the underlying molecular mechanism is
poorly understood.
GC displays distinct biological behaviors according to
histological differentiation [2, 3], and the prognosis of
GC patients is closely associated with histological classifi-
cation: The 5-year survival rates of GC patients are 90 %,
50 %–60 %, and 10 %–15 % for GC Stages I, II, and III,
respectively [4]. Thus, it is critical to elucidate the regula-
tory mechanism of GC cell differentiation, and previous
studies have investigated the mechanism of induced dif-
ferentiation in GC cells. Sakamoto et al. determined that
in addition to intestinal transcription factor caudal type
homeobox 2, epidermal growth factor receptor (EGFR)
activation induces LI-cadherin expression and partici-
pates in the intestinal differentiation in GC [5]. Wei et al.
reported that P27 regulation by glycogen synthase
kinase-3beta results in hexamethylene bisacetamide-
induced differentiation of human GC cells [6]. Hsu et al.
found that the loss of RUNX3 expression correlates with
GC differentiation [7]. However, few reports have been
published on proteins related to the differentiation and
proliferation of GC cells.
Previously, we determined—using 2D gel electro-
phoresis and mass spectrometry—that the expression
of mitogen-activated protein kinase activator with
WD40 repeats (MAWD) and MAWD-binding protein
(MAWBP) was markedly attenuated in GC tissues.
These proteins interacted and formed complexes in
GC cells, and this might play a major role in GC
carcinogenesis [8].
The effects of MAWD in cancers have been de-
scribed in a few reports. MAWD is evolutionarily con-
served and expressed in diverse tissues [9, 10]. Iriyama
and colleagues attempted to detect MAWD-related
proteins by using the conventional two-hybrid tech-
nique and found that MAWBP can bind to MAWD
[10]. Buess et al. reported complete or partial allelic
loss of MAWD in 45.2 % (75/166) of colorectal
cancers [11]. Jung et al. found that MAWD bound to
NM23-H1 and that this created a complex that inter-
acted with, and potentiated the activity of, p53 [12].
Dong et al. detected chromosomal deletions in pros-
tate cancer that overlapped with the MAWD location
[13]. Matsuda et al. determined that MAWD was over-
expressed in 45.6 % (21/46) of human breast tumor tis-
sues and promoted anchorage-independent cell growth
[9]. Kim et al. reported MAWD upregulation in 50.8 %
(30/59) of adenomas and 70.7 % (87/123) of colorectal
cancers [14]. Lastly, Halder et al. found that serine-
threonine kinase receptor-associated protein, or STRAP,
was upregulated in 60 % (12/20) of colon and 78 % (11/14)
of lung carcinomas [15]. However, no reports have been
published on the function of MAWD in GC, and little is
known about MAWBP other than that it can interact with
MAWD.
MAWD, as the name suggests, contains a WD40
repeat domain [16]. Datta et al. showed that MAWD
recruits Smad7 and forms a complex that increases the
inhibition of transforming growth factor-beta (TGF-
beta) signaling [17, 18]. We hypothesized that MAWD
and MAWBP interactions play a key role in the differ-
entiation of GC. Therefore, we investigated the rela-
tionship between the expression of MAWD/MAWBP
and the differentiation grade of GC by using clinical
samples, and we also examined the expression of
differentiation-related proteins in MAWD/MAWBP-
overexpressing GC cells and xenografts. Lastly, we
determined whether MAWD and MAWBP induce
differentiation through TGF-beta signaling in GC. Re-
search on proteins that influence the differentiation of
GC will not only contribute to the diagnosis of GC: it
will also help guide GC treatment.
Methods
Sample collection
Clinical data and GC samples were collected from
Beijing Cancer Hospital of Peking University, Beijing,
China, from January 2011 to June 2013. None of the pa-
tients received chemotherapy or radiotherapy before
tissue samples were obtained. All histological diagnoses
were confirmed by experienced pathologists at the hos-
pital. Written informed consent was obtained from all
patients regarding the use of the collected samples in
research studies. The patient records and information
were anonymized and de-identified before analysis. The
research project and the informed consent were exam-
ined and certified by the Ethics Committee of the
School of Oncology, Peking University (Beijing Cancer
Hospital, China) (No. ECBCH-2011228).
Immunohistochemistry (IHC) and tissue microarray (TMA)
The gastric TMA was constructed using a tissue array-
ing instrument (Beecher Instruments, Silver Spring,
USA), as described previously [19]. The avidin-biotin-
peroxidase protocol was used for IHC. The antibodies
used were against MAWBP (1:100; custom-made, clone
number AbM51007) and MAWD (1:300; custom-made,
clone number AbP61014) [8], and TGF-beta (1:100;
cat# ab66043, Abcam, Cambridge, UK), E-cadherin
(1:100; cat# 610182, BD, Franklin, USA), and pepsin-
ogen C (PGC) (1:150; cat# R31924, Sigma, Cambridge,
USA). Samples were incubated with antibodies at 4 °C
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overnight and visualized using the DAB kit (Dako,
Glostrup, Denmark). All sections were examined and
scored by 2 pathologists in a blinded evaluation. Stain-
ing was scored based on intensity and proportion. The
signal intensity was scored as 0, no staining; 1+, low
intensity; 2+, moderate intensity; or 3+, high intensity.
The extent of surface area containing the target protein
was scored on a scale of 0–3: (0,: no staining; 1+: present,
but <20 %; 2+: 20 %–50 %; and 3+: >50 %). The positiv-
ity score was calculated by multiplying staining inten-
sity and surface area data by tissue compartment
(range: 0–9), and the composite scores were separated
using a four-tier system (negative: 0–1; 1+: 2–4; 2+: 5–7;
and 3+: 8–9).
Prediction for potential MAWD and MAWBP protein-protein
interaction (PPI) networks
The PPI network provides an integrative view of mo-
lecular processes. The human protein interaction net-
work was retrieved from http://www.hprd.org/; MAWD-
and MAWBP- interacting proteins were then searched
for candidate protein-interaction sequence motifs (tri-
mers and tetramers).
Plasmid construction
We reconstructed MAWD and MAWBP expression vec-
tors using pcDNA3.1 B (−). Total RNA was extracted
from 19-week-old fetal liver. MAWD and MAWBP
cDNAs were produced using reverse-transcription PCR
(RT-PCR). The MAWD primers were the following: for-
ward: 5’-CGCGGATCCATGGCAATGAGACA GACG-3’,
reverse: 5’-CCCAAGCTTTCAGGCCTTAACATCAGG-3’.
The amplicons were 1053 bp in size. The MAWBP primers
were the following: forward: 5’- AACTTGGTCG ACCAG
CTTGCAAGGAAAATG-3’, reverse: 5’-ATAACTCGAGC-
TAGGCTGTCAGTGT GCC-3’. The amplicons were 867
bp in size. PCR was performed as follows: the reaction was
initiated using a 5-min incubation at 94 °C, and this was
followed by 35 cycles of 94 °C for 45 s, 56 °C for 45 s, and
72 °C for 60 s, and then the reaction was terminated after a
10-min extension at 72 °C. Products were purified through
gel extraction, and the recombinant plasmids were trans-
ferred into Escherichia coli DH5α and then identified by
performing restriction-enzyme digestion and sequencing
analysis.
Cell culture and transfection
The cell line SGC7901 was routinely maintained as pre-
viously described [20]. SGC7901 cells were selected and
cultured at 60 %–70 % confluence in 35-mm plates and
then transfected with recombinant MAWD and MAWBP
plasmids or empty vector by using Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA). MAWD and MAWBP
plasmids were co-transfected into SGC7901 cells, and at
48 h post-transfection, the cells were seeded in selection
medium containing 400 μg/mL G418 and cultured for
21 days to screen for stable clones.
RT-PCR and western blotting
To confirm efficient transfection, RT-PCR and western
blotting were performed. Total RNA was extracted using
Trizol (Invitrogen) and 5 μg of the RNA was reverse tran-
scribed and PCR-amplified. The primers used and the
amplicon sizes were the following: MAWD: forward, 5’-G
GGACAGGATAAACTTTAGC-3’, and reverse, 5’-AGCA
TGATCCCAAAGTCG AAC-3’ (amplicon size, 162 bp);
and MAWBP: forward, 5’-GGGTCTGCACACGCTGT
TC-3’, and reverse: 5’-TAATGTCAACCCTTCCGTCT-3
(132 bp). The internal control, beta-actin, was processed
concurrently with all specimens. The other primers used
were the following: E-cadherin: forward, 5’-TGATTCTGC
TGCTCTTGCTG-3’, and reverse, 5’-CTCTTCTCCGCC
TCCTTCTT-3’ (122 bp); N-cadherin: forward, 5’-CGTG
AAGGTTTGCCAGTGT-3’, and reverse, 5’- CAGCACAA
GGATAAGCAGGA-3’ (130 bp); PGC: forward: 5’-CG
TCC ACCTACTCCACCAAT-3’, and reverse, 5’-CACTC
AA GCCGAACTCCTG-3’(132 bp); and Snail: forward, 5’-
CCAGAGTTTACCTTCCAGCA G-3’, and reverse, 5’-G
ACA GAGTCCCAGATGAGCA-3’ (214 bp). All primers
were synthesized by Sangon Biotech (Shanghai) Co., Ltd.
(Shanghai, China).
For western blotting, cell extracts were prepared and
then the proteins (50 μg) were separated on 12 % SDS-
PAGE and transferred to PVDF membranes. The blots
were stained (overnight, 4 °C) with the following antibodies
(diluted in blocking buffer): anti-MAWD (1:500), anti-
MAWBP (1:500), anti-Snail (1:1000; cat# C15D3, Cell
Signaling, Danvers, USA), anti-E-cadherin (1:1000), anti-N-
cadherin (1:1000; cat# 610921, BD), anti-PGC (1:1000), and
anti-p-Smad2 (1:500; cat# AB3849, Millipore, Temecula,
USA). The immunoreactive bands were detected using
Super Signal West Dura Extended Duration Substrate
(Thermo Scientific, Rockford, USA). These experiments
were repeated thrice.
Immunofluorescence
Cells were grown on glass slides, washed with PBS,
methanol-fixed for 10 min, and then processed for im-
munofluorescence. Cells were exposed to antibodies
against E-cadherin, N-cadherin, Snail, PGC, and p-Smad2
(all diluted 1:50) overnight at 4 °C, and then incubated for
60 min with fluorophore-conjugated secondary antibodies;
nuclei were stained with 4′,6-diamidino-2-phenylindole
(DAPI). Cells were examined using a Confocal Fluores-
cence Imaging Microscope TCS-SP5 (Leica, Mannheim,
Germany). Three repeated scan results of mean fluores-
cence intensity were analyzed.
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Alkaline phosphatase (AKP) assay
The Alkaline Phosphatase Assay Kit (Jiancheng Bio-
engineering Institute, Nanjing, China) was used for
measuring intracellular AKP activity. We used 3 hree
holes for the detection and repeated this test thrice.
Washed cells (1 × 106) were homogenized in assay
buffer, resuspended in 500 μL of PBS, and then lysed
through ultrasonication. Assay and reaction buffers
were added to 5 μL of cell lysates and incubated for
15 min at 37 °C, and then 150 μL of the color develop-
ment reagent was added and mixed. Absorbance was
measured at 520 nm using an iMark Microplate
Reader.
Tumorigenicity assay in nude mice
Transfected cells were washed twice and resuspended
in 1× Hank’s buffer at a concentration of 5 × 106 cells/
mL. A 100-μL cell suspension was then injected sub-
cutaneously into the left dorsal flank of 15 5-week-old
female nude mice; the right side was inoculated with
SGC7901 cells transfected with vector alone and this
served as the control. The larger (a) and smaller (b)
tumor diameters were measured every week, and tumor
volume was calculated as a × b2 × 0.5. At 3.5 weeks after
injections, the mice were anesthetized with high-
concentration diethyl ether until they died. Tumor
specimens were split and collected. RT-PCR (described
above) was used to analyze MAWD and MAWBP
expression, and IHC analysis was used for detecting
MAWBP, MAWD, TGF-beta, E-cadherin, and PGC
protein expression. All animal procedures were ap-
proved by the Ethics Committee of the School of
Oncology, Peking University (Beijing Cancer Hospital,
China).
Statistical analysis
Statistical analyses were performed using Statistic Pack-
age for Social Science (SPSS) version 16.0. The χ2 test
was used to define significant differences and univariate
analysis among the pathological samples. P < 0.05 was
considered statistically significant. The Spearman rho
test was performed to evaluate the protein correlations.
The Kaplan–Meier method was used for predicting pa-
tient overall survival according to levels of MAWD and
MAWBP expression. Student’s t test was used in meas-
urement data.
Results
Characterization of MAWD and MAWBP coexpression and
clinical outcome in gastric tumor
We compared the expression levels of MAWD and
MAWBP proteins in the TMA that contained 223 GC
samples and adjacent normal tissues. GC tissues showed
faint or negative MAWD and MAWBP expression.
Representative IHC staining is shown in Fig. 1a. The rate
of positive MAWD expression in gastric tumor tissues
was 75/223 (32.2 %), which was lower than that in nor-
mal samples (51/86; 59.3 %) (Table 1). MAWBP showed
the same expression pattern as MAWD did. The positiv-
ity rate of MAWBP in gastric tumor tissues was 62/223
(26.6 %), whereas it was 50/81 (61.7 %) in normal tissues
(Table 1) (Fig. 1a). MAWD and MAWBP expression
displayed statistically significant correlation (P < 0.001)
(Table 2).
Further examination of the samples revealed that
well-differentiated cancers tended to show uniform
MAWD and MAWBP expression. The Kaplan–Meier
survival curve indicated that prognosis was better for
patients who expressed MAWD and MAWBP at high
levels than for patients who expressed the proteins at
low levels (P < 0.05) (Fig. 1b). These data suggest that
analysis of the expression of both MAWD and
MAWBP should provide useful information and might
enhance the identification of differentiation grade and
prognosis in patients.
Correlation of TGF-beta, E-cadherin, and PGC protein
expression with MAWD and MAWBP in GC tumors
Given the clear relationship between MAWD and MAWBP
expression and differentiation and the correlation of their
expression with TGF-beta signaling, we performed TMA
analysis for TGF-beta, E-cadherin, and PGC, which are GC
differentiation-related proteins (Fig. 1c). The positive stain-
ing rates for these differentiation-related proteins in tumor
and normal tissues were, respectively, the following
(Table 1): TGF-beta, 105/223 (47.1 %) and 54/87 (62.1 %)
(P < 0.05); E-cadherin, 95/223 (42.6 %) and 66/95 (69.5 %)
(P < 0.001); and PGC, 86/223 (38.6 %) and 72/100 (72 %)
(P < 0.001).
Relationship analysis revealed that MAWD and
MAWBP expression was significantly correlated with
the expression of TGF-beta (P < 0.001) and E-cadherin
(P < 0.05) (Tables 3, 4). The results of Spearman rho test
indicated the expression levels of MAWBP, MAWD,
TGF-beta, and E-cadherin were correlated with each other
(P < 0.05), and that the expression of E-cadherin was
correlated with that of PGC (P < 0.001) (Table 5). Table 6
presents a summary of our analysis of patient clinicopath-
ologic characteristics in relation to the expression level of
each of the aforementioned proteins.
Overexpression of MAWD and MAWBP in GC cells
Previously, we detected endogenous expression of MAWD
and MAWBP in GC cell lines using real-time PCR and
western blotting. We found that MAWD and MAWBP are
expressed at low levels in SGC7901 cells [21]. Thus, we
selected SGC7901 as the test cell line and transfected the
cells with the MAWD and MAWBP eukaryotic expression
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Fig. 1 (See legend on next page.)
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vectors that we constructed; the cells were transfected with
each of the vectors alone or with both vectors. We named
these groups of cells MAWD (overexpressing MAWD
alone), MAWBP (overexpressing MAWBP alone), MAW
BP&D (co-overexpressing MAWBP and MAWD), and
Vector. Next, we isolated G418-resistant clones in order to
obtain cells that stably overexpressed the proteins, and we
used RT-PCR and western blotting to check for efficient
expression of MAWD and MAWBP (P < 0.001; Fig. 2a, b).
MAWD and MAWBP coexpression induces differentiation
in GC cells
We performed western blotting, semiquantitative RT-
PCR, and confocal microscopy in order to examine
the expression of the differentiation-related proteins
E-cadherin, PGC, N-cadherin, and Snail in transfected
cells. E-cadherin and PGC were used as differentiation
markers of the gastric mucosa. The expression of E-
cadherin protein and mRNA was increased relative to
control in the MAWBP&D group and was weakest in
the Vector group (Fig. 3a, b), and this was also shown
by the results of confocal microscopy and mean
fluorescence-intensity measurements (P < 0.001; Fig. 3d).
The expression of N-cadherin was inversely associated
with that of E-cadherin in the MAWBP&D and Vector
groups (P < 0.05; Fig. 3a, b, d). However, the expression
of PGC showed the same trend as E-cadherin expres-
sion: PGC expression was increased relative to control
in the MAWBP&D group and was lowest in the Vector
group (P < 0.001; Fig. 4). Lastly, the expression of Snail
protein was weakest in the MAWBP&D group and
increased in the Vector group (P < 0.05; Fig. 4a, c). We
found that cells in the MAWBP&D group were well
organized and appeared to exhibit polarity, whereas the
cells in the control group were disorganized (Fig. 3d,
Fig. 4c).
We also measured AKP activity to further analyze the
differentiation level of various transfected cells. The AKP
levels were the following (in U/g protein): MAWD group,
77.3 ± 5.8; MAWBP group, 74.8 ± 3.9; MAWBP&D group,
51.6 ± 12.1; and Vector group, 91.9 ± 3.5. AKP activity was
lowest in the MAWBP&D group and highest in the
control group (P < 0.001; Fig. 3c). Collectively, the afore-
mentioned results suggest that MAWD and MAWBP
induce the differentiation of GC cells.
Potential MAWD and MAWBP protein-protein interaction
(PPI) networks
PPI networks were identified here and these provided
complementary evidence to our previous proteomics
studies on MAWD and MAWBP interactions. MAWD
interacted with proteins related to the TGF-beta signal-
ing pathway, including TGF-beta and Smad2 (Fig. 5a).
Coexpression of MAWD and MAWBP influences the
TGF-beta signaling pathway
Western blotting analysis performed on the transfected
cells revealed that p-Smad2 levels were lowest in the
MAWBP&D group and highest in the Vector group
(Fig. 5b). Furthermore, the nuclear-translocation cap-
acity of p-Smad2 was lowest in the MAWBP&D group,
(See figure on previous page.)
Fig. 1 Comparison of MAWBP, MAWD, TGF-beta, E-cadherin, and PGC expression in GC and normal tissues by using IHC. (a) Comparison of
MAWBP and MAWD expression in GC and normal tissues by means of TMA and IHC analysis (100×; 400× in the lower right corner). Weak MAWBP
(a) and MAWD (b) protein staining in poorly differentiated carcinoma; expression of MAWBP (c) and MAWD (d) in intestinal metaplasia; strong
positive staining of MAWBP (e) and MAWD (f) in normal tissues (P < 0.001). (b) Kaplan–Meier analysis of overall survival in GC patients expressing
different levels of MAWBP and MAWD. (a) Green and blue lines represent the survival curves of patients expressing high and low levels of MAWBP (P
< 0.05). (b) Green and blue lines represent the survival curves of patients expressing MAWD at high and low levels (P < 0.05). (c) Combined MAWBP
and MAWD expression for analysis of overall survival; prognosis was better for patients who expressed high levels of MAWBP and MAWD than for pa-
tients who expressed the proteins at low levels (P < 0.05). (c) Comparison of TGF-beta, E-cadherin, and PGC expression in GC and normal
tissues by using TMA and IHC analysis (100×; 400× in the lower right corner). Weak TGF-beta (a), E-cadherin (b), and PGC (c) protein
staining in poorly differentiated carcinoma; staining for TGF-beta (d), E-cadherin (e), and PGC (f) in intestinal metaplasia; strong positive
staining for TGF-beta (g), E-cadherin (h), and PGC (i) in normal tissues (P < 0.05)
Table 1 Comparison of MAWBP, MAWD, TGF-beta, E-cadherin,
and PGC protein expression in GC and normal tissues
Expression
Protein Tumor Normal P-value
(% positive) (% positive)
MAWBP 62/223 (26.6) 50/81 (61.7) <0.001
MAWD 75/223 (32.2) 51/86 (59.3) <0.001
TGF-beta 105/223 (47.1) 54/87 (62.1) 0.012
E-cadherin 95/223 (42.6) 66/95 (69.5) <0.001
PGC 86/223 (38.6) 72/100 (72) <0.001
Table 2 Correlation of MAWBP and MAWD expression in GC
Expression MAWBP
Protein Positive (%) Negative (%) P-value
MAWD Positive 32/215 (14.9) 42/215 (19.5) 0.001
Negative 26/215 (12.1) 115/215 (53.5)
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as shown by confocal microscopy (Fig. 5c), and the mean
fluorescence intensity of p-Smad2 was highest in the
Vector group (P < 0.05; Fig. 5d). These results indicate
that the MAWBP-MAWD complex could effectively
suppress TGF-beta signaling by inhibiting downstream
phosphorylation.
Overexpression of MAWD and MAWBP affects the
tumorigenicity of GC cells
The results of in vivo experiments showed that tumor
growth was slower in nude mice injected with cells of
the MAWD, MAWBP, and MAWBP&D groups than in
mice injected with cells of the control group (Fig. 6a).
Tumor growth was clearly slower after injection with cells
of the MAWD and MAWBP groups as compared to that
after injection of the Vector-group cells (P < 0.001; Fig. 6a).
Moreover, the tumor volume in the MAWD and MAWBP
overexpression groups was lower than that in the Vector
group (P < 0.001; Fig. 6b). RT-PCR results showed that
MAWD and MAWBP were overexpressed in xenografts
derived from cells transfected with MAWD and MAWBP
(Fig. 6c), and this was confirmed by the immunostaining
results (Fig. 6d). We also used IHC to evaluate the expres-
sion of TGF-beta, E-cadherin, and PGC in excised xeno-
graft tumors; the proteins showed varied expression in
distinct groups but the expression was higher in the
MAWD and MAWBP overexpression groups than in
other groups (Fig. 6d). In Additional file 1, we present a
model to illustrate the molecular functions of MAWD
and MAWBP in the differentiation of GC cells.
Discussion
In this study, we systematically confirmed the correlation
between the overexpression of MAWD and MAWBP and
differentiation in GC tissues and cell lines. More import-
antly, we found that the coexpression of MAWD and
MAWBP correlated with the expression of E-cadherin
and PGC, which are differentiation-related factors in
gastric cells. Furthermore, the expression of N-cadherin,
Snail, and p-Smad2 was inversely associated with that of
E-cadherin and PGC, and overexpression of MAWD and
MAWBP reduced the nuclear translocation of Smad2 by
attenuating its phosphorylation.
Previously, we reported proteomic data acquired
from screening GC protein profiles, including those of
MAWD and MAWBP, and we showed that these pro-
teins can form a complex [8]. Thus, combined analysis
of MAWD and MAWBP expression should provide
useful information for uncovering the roles of these
proteins in GC. We verified the expression of these 2
potential GC-related proteins in several GC tissue
samples by means of TMA and IHC analyses. We
found that MAWD and MAWBP were expressed at
low levels in GC tissues, and that the expression of
TGF-beta was also substantially decreased in GC; the
expression levels of all 3 of these proteins were corre-
lated. These results agree with previous observations.
The proteins were also related to GC differentiation
grade and patient prognosis. The survival times of
patients who expressed high levels of MAWD and
MAWBP were longer than those of patients who
expressed these proteins at low levels.
Next, we analyzed the relationship between MAWD and
MAWBP expression and differentiation in GC tissues by
examining the differentiation-related proteins E-cadherin
and PGC. E-cadherin plays a major role in cell-cell
interactions, and a reduction in E-cadherin expression
is correlated with de-differentiation, invasiveness, and
Table 3 Correlation of MAWD expression with TGF-beta,
E-cadherin, and PGC expression in GC
Expression MAWD
Protein Positive (%) Negative (%) P-value
TGF-beta Positive 49/209 (23.4) 52/209 (24.9) <0.001
Negative 24/209 (11.5) 84/209 (40.2)
E-cadherin Positive 37/200 (18.5) 49/208 (23.6) 0.039
Negative 33/200 (13.9) 81/200 (40.5)
PGC Positive 35/218 (16.5) 48/218 (22) 0.45
Negative 39/218 (17.9) 96/218 (44)
Table 4 Correlation of MAWBP expression with TGF-beta,
E-cadherin, and PGC expression in GC
Expression MAWBP
Protein Positive (%) Negative (%) P-value
TGF-beta Positive 43/216 (19.9) 59/216 (27.3) <0.001
Negative 13/216 (6.0) 101/216 (46.8)
E-cadherin Positive 31/208 (14.9 58/208 (27.9) 0.026
Negative 25/208 (15.7) 94/208 (45.2)
PGC Positive 28/223 (12.0) 57/223 (25.6) 0.112
Negative 32/223 (14.3) 106/223 (47.5)
Table 5 Correlations among the expression patterns of 5 proteins
in GC
Correlation coefficient (ρ), N = 223
MAWBP MAWD TGF-beta E-cadherin PGC
MAWBP 1 0.266** 0.350** 0.160* 0.107
MAWD 1 0.267** 0.146* 0.136*
TGF-beta 1 0.161* 0.048
E-cadherin 1 0.403**
PGC 1
*P < 0.05, **P < 0.001
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metastatic activity of carcinoma cells [22]. PGC is an
aspartic protease produced mainly by the gastric mu-
cosa [23], and the expression of PGC is used as a bio-
marker for the gastric mucosa. Moreover, a change in
PGC expression might reflect gastric-cell differentiation
[24], and the levels of E-cadherin and PGC can reflect
the severity of gastric lesions or gastric-cell differenti-
ation [25, 26]. Here, we detected E-cadherin and PGC
expression in the TMA, and we found that whereas the
expression of MAWD, MAWBP, and TGF-beta was
clearly correlated with that of E-cadherin, PGC expres-
sion was correlated with MAWD expression. These
results provided evidence indicating that the expression
of MAWD and MAWBP is closely related with the dif-
ferentiation of GC.
We used PPI bioinformatic predictions to extract all
available human proteins that are related to MAWD
and MAWBP, and we described their global proper-
ties. PPI bioinformatic predictions could provide com-
plementary evidence for genome-wide experimental
Table 6 Univariate analysis with clinicopathological features in GC
Features MAWBP expression (%) MAWD expression (%) TGF-beta expression (%) E-cadherin expression (%) PGC expression (%)
Sex
Male 37/151(24.5) 44/146(30.1) 69/149(46.3) 60/143(41.9) 54/152(35.5)
Female 22/71(30.9) 25/68(36.8) 29/65(44.6) 35/64(54.6) 36/72(50.0)
P-value 0.195 0.209 0.469 0.061 0.028
Age at diagnosis
<60 24/91(26.3) 36/89(40.4) 41/88(46.6) 38/83(45.8) 36/91(38.8)
≥60 35/128(27.3) 31/121(29.2) 55/122(45.1) 54/121(44.6) 52/129(38.9)
P-value 0.500 0.017 0.469 0.492 0.512
TNM stage
I 12/20(60.0) 9/20(45.0) 11/20(55.0) 11/20(50.0) 10/21(47.6)
II 18/78(17.2) 24/75(32.0) 31/75(41.3) 28/72(38.9) 32/78(41.0)
III 11/64(17.2) 14/60(23.3) 27/61(44.3) 32/61(52.5) 29/65(44.6)
IV 18/54(33.3) 21/52(40.3) 27/51(52.9) 21/48(43.8) 17/53(32.1)
P-value 0.001 0.160 0.501 0.355 0.481
Tumor depth
T1-T2 16/45(36) 19/46(41.3) 25/45(55.6) 17/42(40.5) 18/47(38.3)
T3-T4 43/173(24.9) 49/163(30.1) 72/164(43.9) 75/161(46.6) 70/172(40.7)
P-value 0.107 0.105 0.111 0.298 0.451
Lymph node status
N0 21/52(40.4) 20/52(38.5) 27/51(52.9) 24/47(51.1) 23/54(42.6)
N1 18/77(23.4) 24/74(32.4) 32/73(43.8) 29/77(37.7) 36/78(46.2)
N3 12/68(17.6) 18/62(29.0) 29/66(43.9) 31/62(50.0) 23/66(34.8)
N4 8/19(42.1) 6/19(31.6) 9/17(52.9) 8/15(53.3) 6/19(31.6)
P-value 0.016 0.760 0.681 0.339 0.452
Distant metastasis
M0 51/190(26.8) 56/183(30.6) 81/182(44.5) 82/179(45.8) 78/192(40.6)
M1 8/28(28.6) 12/26(46.2) 16/27(59.3) 10/24(41.7) 10/27(37.0)
P-value 0.504 0.089 0.110 0.437 0.446
Differentiation
D1 6/12(50.0) 4/11(36.3) 9/12(75.0) 8/12(66.7) 1/13(7.6)
D2 30/78(38.5) 28/76(36.8) 41/74(55.4) 36/71(50.7) 32/79(40.5)
D3 22/123(17.9) 35/120(29.2) 45/120(37.5) 47/116(40.5) 52/125(41.6)
P-value 0.031 0.649 0.006 0.046 0.035
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studies. The function annotation of MAWD-interacting
proteins indicated the potential involvement of MAWD
and MAWBP in TGF-beta signaling.
We next evaluated the relationship between MAWD
and MAWBP expression and differentiation in GC cells.
We constructed eukaryotic expression vectors of MA
WD and MAWBP, transfected them alone or together
into SGC7901 cells, and examined the expression of the
differentiation-related proteins E-cadherin and PGC in
various transfected clones. We found that E-cadherin
and PGC were strongly expressed in cells cotransfected
with MAWBP and MAWD. Confocal analysis revealed
that the cells in the MAWBP&D group were well orga-
nized and appeared to exhibit polarity, whereas the cells
in the control group were disorganized. Furthermore,
the results of in vivo xperiments showed that tumor
growth was slower in nude mice injected with cells of
the MAWD, MAWBP, and MAWBP&D groups as com-
pared with that in mice injected with cells of the control
group. E-cadherin and PGC were also expressed at the
highest level in the xenograft tumors of the MAWBP&D
group. These results indicate that the cells in the
MAWBP&D group were differentiated to a greater ex-
tent than the cells in the other groups.
A malignant gastric tumor cell might also produce a
particular isozyme of an enzyme, as illustrated most clearly
in the case of AKP production. AKP activity was reported
to be inversely proportional to GC cell differentiation [27].
We measured AKP activity in various transfected cells and
found that the activity was lowest in the MAWBP&D-
transfected clones, but highest in the Vector group. These
results also suggested that the degree of differentiation was
highest in the MAWBP&D clones. Thus, overexpression of
both MAWD and MAWBP induced GC differentiation.
E-cadherin is expressed by most epithelial tissues, and
certain proteins expressed in cancer cells are also related
to E-cadherin, such as Snail, Smad2, and Smad3. Con-
versely, N-cadherin is an adhesion molecule that is typically
expressed by mesenchymal cells. The loss of E-cadherin
expression and the gain of N-cadherin expression in cancer
cells, occasionally referred to as “the cadherin switch,” are
functionally significant in cancer progression [28]. Further-
more, the molecule Snail could be related to E-cadherin
because Snail can bind to specific DNA sequences
called E-boxes present in the E-cadherin promoter and
repress transcription [29]. Thus, we measured the ex-
pression levels of N-cadherin and Snail in the trans-
fected GC cells; whereas E-cadherin was downregulated
Fig. 2 Stable overexpression of MAWBP and MAWD in the GC cell line SGC7901. (a) Expression of MAWBP and MAWD was detected in stable
clones by means of RT-PCR and western blotting. (b) The mRNA and protein levels of MAWBP and MAWD were higher in stable clones than in
control cells (P < 0.001)
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and N-cadherin was upregulated in control SGC7901
cells, E-cadherin was upregulated and N-cadherin was
downregulated in MAWBP&D-cotransfected SGC7901
cells. Moreover, in MAWBP&D-cotransfected cells, we
also noted a reduction in the expression of Snail, a
molecule that can be induced by TGF-beta stimulation
Fig. 3 Expression of E-cadherin and N-cadherin in GC cells overexpressing MAWBP and MAWD. (a) E-cadherin and N-cadherin protein levels
were measured through western blotting. E-cadherin expression was increased relative to control in the MAWBP and MAWBP&D groups and
was weakest in the Vector group, and N-cadherin levels were decreased in the MAWBP&D group. (b) E-cadherin and N-cadherin mRNA levels
were estimated using semiquantitative RT-PCR. E-cadherin expression was again elevated in the MAWBP and MAWBP&D groups and weakest
in the Vector group, and N-cadherin expression was decreased in the MAWBP&D group. (c) AKP activity measurements revealed that the AKP
level was lowest in the MAWBP&D group and highest in the control group (P < 0.05). (d) E-cadherin and N-cadherin protein expression was
analyzed using confocal microscopy. The mean fluorescence intensity shows that E-cadherin expression was increased in the MAWBP&D group
(P < 0.001) and N-cadherin expression was elevated in the Vector group (P < 0.05). The cells in the MAWBP&D group were morphologically well
organized and appeared to exhibit polarity, whereas the cells in the control group were disorganized
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[30]. MAWD was found to recruit Smad7 and form a
complex that inhibited TGF-beta signaling. Therefore,
we evaluated TGF-beta activity in different transfected
cells by examining the phosphorylation level and
nuclear translocation of Smad2. We found that the
p-Smad2 level was lowest in the cells of the MAWBP&D
group but highest in the control-group cells, and that
the nuclear-translocation ability of p-Smad2 was also
weakest in the cotransfected cells. Our results suggest
that MAWD cooperates with MAWBP to inhibit the
Fig. 4 Expression of PGC and Snail in GC cells overexpressing MAWBP and MAWD. (a) PGC and Snail protein levels were measured through western
blotting. PGC expression was highest in the MAWBP&D group (P < 0.001) and lowest in the Vector group, whereas Snail expression was weakest in the
MAWBP&D group (P < 0.001). (b) PGC and Snail mRNA levels were estimated using semiquantitative RT-PCR. PGC expression was lowest in the Vector
group, but N-cadherin expression was highest in the Vector group (P < 0.05). (c) PGC and Snail protein expression levels were analyzed using a confocal
microscope. The mean fluorescence intensity shows that PGC expression was strongest in the MAWBP&D group (P < 0.001) and Snail expression was
strongest in the Vector group (P < 0.05). Once again, the cells in the MAWBP&D group were morphologically well organized, but the Vector-group cells
were disorganized
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TGF-beta signaling pathway, which decreases Snail ex-
pression and increases E-cadherin expression; this, in
turn, results in the well-differentiated characteristics of
MAWBP&D-cotransfected cells.
In conclusion, MAWD and MAWBP were downregu-
lated in GC tissues and associated with the differenti-
ation grade of these tissues. Low MAWD and MAWBP
expression levels were associated with poor survival of
patients. The results of in vitro and in vivo experiments
demonstrated that the co-overexpression of MAWD
and MAWBP induced GC differentiation. Lastly, detec-
tion of p-Smad2 levels and its nuclear translocation
revealed that MAWD and MAWBP induced the ex-
pression of differentiation-related proteins by modulat-
ing TGF-beta signaling in GC cells.
Conclusions
We discovered that MAWD and MAWBP, which were
downregulated in GC tissues, were associated with dif-
ferentiation in GC tissues. Coexpression of MAWD
Fig. 5 MAWBP and MAWD influence the expression of differentiation-related proteins in GC cells through TGF-beta signaling. (a) Prediction
of MAWBP and MAWD protein-protein interaction networks. A schematic showing the protein interaction network of MAWMP and MAWD,
retrieved from http://www.hprd.org/. (b) Western blotting results showed that the p-Smad2 level was lowest in the MAWBP&D group.
(c-d) Confocal analysis revealed that the nuclear-translocation capacity of p-Smad2 was low in the MAWBP and MAWD overexpression
groups and highest in the Vector group
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and MAWBP was correlated with the expression of the
differentiation-related proteins E-cadherin and PGC in
GC cells. The levels of Snail (a factor that negatively
regulates E-cadherin expression), N-cadherin, and p-
Smad2 were inversely correlated with E-cadherin levels in
cells that coexpressed MAWD and MAWBP. The results
of AKP assays confirmed that these MAWD/MAWBP-
coexpressing cells were differentiated to a greater extent as
compared to control cells. Coexpression of MAWD and
MAWBP also influenced the expression of E-cadherin and
PGC in vivo. Our results suggest that the MAWD and
MAWBP might induce the expression of differentiation-
related proteins through the modulation of TGF-beta
signaling in GC cells (Additional file 1).
Additional file
Additional file 1: Figure S1. A model illustrating the molecular
functions of MAWBP and MAWD in GC. The presence of MAWBP
enhances the inhibitory effect of MAWD on the TGF-beta signaling
pathway. The MAWD-MAWBP complex inhibits the phosphorylation
Fig. 6 Co-overexpression of MAWBP and MAWD influences the tumorigenicity of GC cells. (a-b) Tumors induced by cells of the MAWBP, MAWD,
and MAWBP&D groups were smaller than those induced by cells of the control group (P < 0.001). (c) RT-PCR analysis revealed that MAWBP and
MAWD were overexpressed in xenografts derived from cells transfected with MAWBP and MAWD. (d) IHC analysis for comparison of MAWBP,
MAWD, TGF-beta, E-cadherin, and PGC expression in different xenograft tumors.
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and nuclear translocation of Smads, which influences the expression of
downstream genes, as shown by, for example, the downregulated
expression of the transcription factor Snail. Snail does not efficiently
bind to the E-box upstream of the E-cadherin gene, and thus the
expression of E-cadherin is increased. This pathway influences the
differentiation of GC cells. (TIFF 945 kb)
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